Labrys Biologics Inc., a company focused on treatments for chronic migraine.
Labrys Biologics has acquired worldwide rights to RN-307 from Pfizer Inc. RN-307 is an antibody for the treatment of chronic migraine.
RN-307 was originally developed by Rinat Pharmaceuticals, acquired by Pfizer in 2006.
Funding Rounds (2) - $45.6MUpdate
InterWest invests an average of about $7 - 15 million over the span of their involvement with...
IT and Healthcare VC
Since 1974, Sofinnova Ventures has partnered with entrepreneurs to secure initial funding, build...
venBio LLC is a private equity and venture capital firm specializing in investments in early...
- 06/03/14 -firstwordpharma.com